-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Atara Biotherapeutics, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
- Atara Biotherapeutics, Inc. Current Income Tax Expense (Benefit) for the quarter ending December 31, 2012 was $17K.
- Atara Biotherapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $15K, a 25% increase from 2022.
- Atara Biotherapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $12K, a 73.9% decline from 2021.
- Atara Biotherapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $46K, a 207% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)